GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hyper Corporation Inc (XKRX:065650) » Definitions » Institutional Ownership

Hyper (XKRX:065650) Institutional Ownership : 0.18% (As of May. 26, 2024)


View and export this data going back to 2003. Start your Free Trial

What is Hyper Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Hyper's institutional ownership is 0.18%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Hyper's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Hyper's Float Percentage Of Total Shares Outstanding is 0.00%.

Hyper Institutional Ownership Historical Data

The historical data trend for Hyper's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hyper Institutional Ownership Chart

Hyper Historical Data

The historical data trend for Hyper can be seen below:

2022-11-30 2022-12-31 2023-01-31 2023-02-28 2023-03-31 2023-04-30 2023-05-31 2023-06-30 2023-07-31 2023-08-31
Institutional Ownership 0.32 0.32 0.31 0.31 0.31 0.30 0.17 0.18 0.18 0.18

Hyper Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

Hyper (XKRX:065650) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hyper Corporation Inc (XKRX:065650) » Definitions » Institutional Ownership
Comparable Companies
XKRX:383930 XKRX:298060 XKRX:222110 XKRX:032790 XKRX:115180 XKRX:299660 XKRX:142760 XKRX:036480 XKRX:456570 XKRX:217730 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
N/A
Address
Woolim A-1401, 583, Yangcheon-ro, Gangseo-gu, Seoul, KOR, 07547
Website
http://www.medifron.com
Medifron DBT Co Ltd is a Korean clinical stage biopharmaceutical company. The company is focused on the development of Alzheimer's disease (AD) and neuropathic pain (NP) treatment and AD diagnostics.

Hyper (XKRX:065650) Headlines

No Headlines